Brief: Cleveland Biolabs Says Received Formal Notification From EMA

Statera Biopharma

28/03/2018 23:07

March 28 (Reuters) - Cleveland Biolabs Inc  CBLI.O :
    * CLEVELAND BIOLABS - RECEIVED DAY 120 REVIEW QUESTIONS FROM
EMA
REGARDING MARKETING AUTHORIZATION APPLICATION FOR ENTOLIMOD
    * CLEVELAND BIOLABS - RECEIVED FORMAL NOTIFICATION FROM EMA
THAT
RESPONSES SHOULD BE SUBMITTED TO AGENCY BY SEPT 14

Source text - https://bit.ly/2pNGoDb
Further company coverage:  CBLI.O 

 ((Reuters.Briefs@thomsonreuters.com))